Provided by Tiger Trade Technology Pte. Ltd.

Verastem

7.90
-0.1500-1.86%
Post-market: 7.900.00000.00%19:30 EDT
Volume:1.76M
Turnover:13.99M
Market Cap:715.45M
PE:-3.27
High:8.18
Open:8.00
Low:7.74
Close:8.05
52wk High:10.82
52wk Low:3.43
Shares:90.56M
Float Shares:70.57M
Volume Ratio:1.05
T/O Rate:2.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4143
EPS(LYR):-3.0223
ROE:-471.16%
ROA:-49.59%
PB:14.31
PE(LYR):-2.61

Loading ...

Verastem announces publication of RAMP 201 study in Gynecologic Oncology journal

TIPRANKS
·
Sep 29

Verastem Reports 2-Year RAMP 201 Data for Avutometinib-Defactinib Combo in Recurrent Low-Grade Serous Ovarian Cancer

Reuters
·
Sep 29

Verastem Flags RAMP 201 Biomarker Data for Late-Breaking Oral Presentation at IGCS 2026

Reuters
·
Sep 24

GenFleet Hits over 3-Week High as Cancer Drug Makes Progress on BTD List

Reuters
·
Sep 23

GenFleet Schedules Oct. 15 Investor Call to Release Preliminary Gfh375-Cetuximab Trial Data in KRAS G12D Tumors

Reuters
·
Sep 23

Verastem (VSTM) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Sep 22

Verastem's Shares Not Fully Valuing its Growth Potential, RBC Says

MT Newswires Live
·
Sep 18

RBC Capital Keeps Their Buy Rating on Verastem (VSTM)

TIPRANKS
·
Sep 18

Verastem Initiated at Outperform by Wolfe Research

Dow Jones
·
Sep 17

Wolfe Research Initiates Verastem at Outperform

MT Newswires Live
·
Sep 17

Verastem initiated with an Outperform at Wolfe Research

TIPRANKS
·
Sep 17

Verastem: Avutometinib Plus Defactinib Data De-Risk Efficacy Thesis; Buy Rating Reiterated With Unchanged $18 Price Target

TIPRANKS
·
Sep 12

Verastem Price Target Maintained with a $18.00/Share by BTIG

Dow Jones
·
Sep 11

Verastem Sets Oct. 14 Investor Event to Present New Vs-7375 KRAS G12D Trial Data Across Solid Tumors

Reuters
·
Sep 08

Mizuho Adjusts Price Target on Verastem to $13 From $14, Keeps Outperform Rating

MT Newswires Live
·
Aug 11

Verastem price target lowered to $13 from $14 at Mizuho

TIPRANKS
·
Aug 11

Verastem is Maintained at Buy by Guggenheim

Dow Jones
·
Aug 08

Verastem - Enters Amendment No. 3 to Note Purchase Agreement on August 6, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 07

Verastem - Establishes Initial Notes of $75 Mln and Revenue Notes up to $75 Mln - SEC Filing

THOMSON REUTERS
·
Aug 07

Verastem Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07